Ci Investments Inc. Eli Lilly & CO Transaction History

Ci Investments Inc.

$26.3 Billion
Q3 2024

A detailed history of Ci Investments Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Ci Investments Inc. holds 461,061 shares of LLY stock, worth $354 Million. This represents 1.55% of its overall portfolio holdings.

Number of Shares

461,061

Previous 545,080 15.41%

Holding current value

$354 Million

Previous $494 Million 17.23%

% of portfolio

1.55%

Previous 1.94%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $64.9 Million - $80.7 Million	-84,019 Reduced 15.41%	461,061 $408 Million
Q2 2024 Aug 12, 2024	BUY	$724.87 - $909.04 $2.43 Million - $3.05 Million	3,353 Added 0.62%	545,080 $494 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $17.4 Million - $23.3 Million	-29,353 Reduced 5.14%	541,727 $421 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $157 Million - $185 Million	-298,286 Reduced 34.31%	571,080 $333 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $13.2 Million - $18.2 Million	-30,401 Reduced 3.38%	869,366 $467 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $53.7 Million - $71.8 Million	153,023 Added 20.49%	899,767 $422 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $26.5 Million - $31.1 Million	85,219 Added 12.88%	746,744 $256 Million
Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $55.9 Million - $65.2 Million	173,954 Added 35.68%	661,525 $242 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $38.4 Million - $43.8 Million	129,677 Added 36.23%	487,571 $158 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $18.9 Million - $22.2 Million	-67,861 Reduced 15.94%	357,894 $116 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $16.9 Million - $21 Million	72,152 Added 20.4%	425,755 $122 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $13.3 Million - $16.6 Million	-59,315 Reduced 14.36%	353,603 $97.7 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $73.2 Million - $90 Million	330,106 Added 398.62%	412,918 $95.4 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $602,314 - $779,089	3,336 Added 4.2%	82,812 $19 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $25.6 Million - $33.2 Million	-155,974 Reduced 66.25%	79,476 $14.8 Million
Q4 2020 Feb 09, 2021	SELL	$130.46 - $172.63 $38.1 Million - $50.4 Million	-291,822 Reduced 55.35%	235,450 $39.8 Million
Q3 2020 Nov 09, 2020	BUY	$146.22 - $169.13 $19.6 Million - $22.7 Million	134,154 Added 34.13%	527,272 $78 Million
Q2 2020 Aug 07, 2020	SELL	$136.42 - $164.18 $19.1 Million - $23 Million	-140,180 Reduced 26.29%	393,118 $64.5 Million
Q1 2020 Aug 07, 2020	SELL	$119.05 - $147.35 $14.5 Million - $17.9 Million	-121,493 Reduced 18.55%	533,298 $74 Million
Q4 2019 Feb 11, 2020	BUY	$106.92 - $132.43 $62.9 Million - $77.9 Million	588,252 Added 884.07%	654,791 $86.1 Million
Q3 2019 Nov 08, 2019	BUY	$106.79 - $116.16 $7.11 Million - $7.73 Million	66,539 New	66,539 $7.44 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $133,572 - $157,224	-1,200 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$105.9 - $118.64 $127,080 - $142,368	1,200 New	1,200 $138,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.

Account

Ci Investments Inc. Eli Lilly & CO Transaction History